ISSN: 1300-7777 E-ISSN: 1308-5263
Usage of U7 snRNA in gene therapy of hemoglobin S disorder - is it feasible? [Turk J Hematol]
Turk J Hematol. 2009; 26(3): 159-160

Usage of U7 snRNA in gene therapy of hemoglobin S disorder - is it feasible?

Viroj Wiwanitkit
Wiwanitkit House, Bangkhae, 10160 Bangkok, Thailand

OBJECTIVE: OBJECTIVE: Hemoglobin (Hb) S disorder [beta6(A3)Glu-->Val, GAG-->GTG] is an important hemoglobinopathy with the highest endemicity in Africa.
METHODS: METHODS: Here, the author performs a basic bioinformatics gene ontology study to assess the effect of co-expression between nucleic acid sequence for human Hb S beta globin chain and U7.623.
RESULTS: : According to this study, the analytical results show that fully recovery of hemoglobin in both function and biological process can be got.
CONCLUSION: CONCLUSION: Here, the author proposed that U7 snRNA might be a probable tool for treatment by gene therapy approach in Hb S disorder.

Keywords: hemoglobin S, U7 snRNA


Hemoglobin S hastalığının gen tedavisinde U7 snRNA kullanımı uygun mu?

Viroj Wiwanitkit
Wiwanitkit House, Bangkhae, 10160 Bangkok, Thailand



Viroj Wiwanitkit. Usage of U7 snRNA in gene therapy of hemoglobin S disorder - is it feasible?. Turk J Hematol. 2009; 26(3): 159-160

Corresponding Author: Viroj Wiwanitkit, Thailand


TOOLS
Full Text PDF
Print
Download citation
RIS
EndNote
BibTex
Medlars
Procite
Reference Manager
Share with email
Share
Send email to author

Similar articles
PubMed
Google Scholar


 



Impact Factor (2016) = 0.686